These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1016 related items for PubMed ID: 19465867

  • 1. Pharmacological treatment after acute myocardial infarction from 2001 to 2006: a survey in Italian primary care.
    Filippi A, D'Ambrosio G, Giustini SE, Pecchioli S, Mazzaglia G, Cricelli C.
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):714-8. PubMed ID: 19465867
    [Abstract] [Full Text] [Related]

  • 2. Parabolas of medication use and discontinuation after myocardial infarction--are we closing the treatment gap?
    Hudson M, Richard H, Pilote L.
    Pharmacoepidemiol Drug Saf; 2007 Jul; 16(7):773-85. PubMed ID: 17486661
    [Abstract] [Full Text] [Related]

  • 3. Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction.
    Gasse C, Jacobsen J, Larsen AC, Schmidt EB, Johannesen NL, Videbaek J, Sørensen HT, Johnsen SP.
    Eur J Vasc Endovasc Surg; 2008 Jan; 35(1):51-8. PubMed ID: 17923426
    [Abstract] [Full Text] [Related]

  • 4. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
    Blackburn DF, Dobson RT, Blackburn JL, Wilson TW, Stang MR, Semchuk WM.
    Can J Cardiol; 2005 May 01; 21(6):485-8. PubMed ID: 15917876
    [Abstract] [Full Text] [Related]

  • 5. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis.
    van der Elst ME, Bouvy ML, de Blaey CJ, de Boer A.
    Clin Ther; 2005 Nov 01; 27(11):1806-14. PubMed ID: 16368451
    [Abstract] [Full Text] [Related]

  • 6. Secondary prevention following coronary artery bypass grafting has improved but remains sub-optimal: the need for targeted follow-up.
    Turley AJ, Roberts AP, Morley R, Thornley AR, Owens WA, de Belder MA.
    Interact Cardiovasc Thorac Surg; 2008 Apr 01; 7(2):231-4. PubMed ID: 18234766
    [Abstract] [Full Text] [Related]

  • 7. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC, Tu JV, Ko DT, Alter DA.
    CMAJ; 2008 Oct 21; 179(9):901-8. PubMed ID: 18936455
    [Abstract] [Full Text] [Related]

  • 8. Re: Secondary medical prevention in patients with peripheral arterial disease.
    Schouten O, Welten GM, Bax JJ, Poldermans D.
    Eur J Vasc Endovasc Surg; 2008 Jan 21; 35(1):59-60. PubMed ID: 17719805
    [No Abstract] [Full Text] [Related]

  • 9. Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence.
    Simpson E, Beck C, Richard H, Eisenberg MJ, Pilote L.
    Am Heart J; 2003 Mar 21; 145(3):438-44. PubMed ID: 12660666
    [Abstract] [Full Text] [Related]

  • 10. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS, Bajorek BV.
    J Clin Pharm Ther; 2008 Dec 21; 33(6):591-601. PubMed ID: 19138236
    [Abstract] [Full Text] [Related]

  • 11. Ten-year trends of cardiovascular drug use after myocardial infarction among community-dwelling persons > or =65 years of age.
    Setoguchi S, Glynn RJ, Avorn J, Levin R, Winkelmayer WC.
    Am J Cardiol; 2007 Oct 01; 100(7):1061-7. PubMed ID: 17884362
    [Abstract] [Full Text] [Related]

  • 12. Acute treatment of myocardial infarction in Canada 1999-2002.
    Jackevicius CA, Alter D, Cox J, Daly P, Goodman S, Filate W, Newman A, Tu JV, Canadian Cardiovascular Outcomes Research Team.
    Can J Cardiol; 2005 Feb 01; 21(2):145-52. PubMed ID: 15729413
    [Abstract] [Full Text] [Related]

  • 13. Treatment with statins after acute myocardial infarction in patients >or=80 years: underuse despite general acceptance of drug therapy for secondary prevention.
    Kvan E, Pettersen KI, Landmark K, Reikvam A, INPHARM study investigators.
    Pharmacoepidemiol Drug Saf; 2006 Apr 01; 15(4):261-7. PubMed ID: 16315337
    [Abstract] [Full Text] [Related]

  • 14. Evaluating the effect on patient outcomes of appropriate and inappropriate use of beta-blockers as secondary prevention after myocardial infarction in a medicaid population.
    Fernandes AW, Madhavan SS, Amonkar MM.
    Clin Ther; 2005 May 01; 27(5):630-45. PubMed ID: 15978313
    [Abstract] [Full Text] [Related]

  • 15. Discharge prescriptions following admission for acute myocardial infarction at tertiary care and community hospitals in Quebec.
    Beck CA, Lauzon C, Eisenberg MJ, Huynh T, Dion D, Roux R, Racine N, Carignan S, Diodati JG, Charbonneau F, Lévesque C, Pouliot J J, Pilote L L.
    Can J Cardiol; 2001 Jan 01; 17(1):33-40. PubMed ID: 11173312
    [Abstract] [Full Text] [Related]

  • 16. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX, Ye X, Lee KY, Dupclay L, Plauschinat C.
    Clin Ther; 2008 Jan 01; 30 Pt 2():2217-27. PubMed ID: 19281916
    [Abstract] [Full Text] [Related]

  • 17. Secondary prevention after acute myocardial infarction in four Canadian provinces, 1997-2000.
    Pilote L, Beck CA, Karp I, Alter D, Austin P, Cox J, Humphries K, Jackevicius C, Richard H, Tu JV, Canadian Cardiovascular Outcomes Research Team.
    Can J Cardiol; 2004 Jan 01; 20(1):61-7. PubMed ID: 14968144
    [Abstract] [Full Text] [Related]

  • 18. Initiation of and long-term adherence to secondary preventive drugs after acute myocardial infarction.
    Halvorsen S, Jortveit J, Hasvold P, Thuresson M, Øie E.
    BMC Cardiovasc Disord; 2016 May 31; 16():115. PubMed ID: 27246583
    [Abstract] [Full Text] [Related]

  • 19. Hospital variation in use of secondary preventive medicine after discharge for first acute myocardial infarction during 1995-2004.
    Rasmussen S, Abildstrom SZ, Rasmussen JN, Gislason GH, Schramm TK, Folke F, Køber L, Torp-Pedersen C, Madsen M.
    Med Care; 2008 Jan 31; 46(1):70-7. PubMed ID: 18162858
    [Abstract] [Full Text] [Related]

  • 20. Combined secondary prevention after hospitalization for myocardial infarction in France: analysis from a large administrative database.
    Tuppin P, Neumann A, Danchin N, Weill A, Ricordeau P, de Peretti C, Allemand H.
    Arch Cardiovasc Dis; 2009 Apr 31; 102(4):279-92. PubMed ID: 19427605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.